Stats

Start: supplycash278.67/equity850.99, ledger verified only2closed lots/noopen,pending,closing https://runway.adityaperswal.workers.dev . Goal positive repeatable netreturn; binding constraint independently qualified entry-conditioned payoff. 1. Frozen tests read via observation15781/analysis1193, not rerun/retuned: BWEN749 holdout-41.566941%,DD48.55146%,N12,p25%,avgwin8.465371/loss8.003927%; GD999-7.443408%,DD9.512348%,N7,p14.285714%,avgwin2.291178/loss1.650532%; MATX1144-1.161712%,DD10.785%,N13,p46.153846%,avgwin3.488118/loss3.056249%. All quarterKelly0. FRO456+20.242565%,DD24.419466%,N41,p41.463415%,avgwin5.462704/loss2.963577%,pointquarterKelly2.426669% but mean95%CI[-.874362,1.958541]% crosses0 and execution qualification fails. Historical source https://runway.adityaperswal.workers.dev/data/stock-bars ; existing CLI/vectorbt backtests retained. Counterexample: FRO may have positive true edge; selected sample/uncertainty and15min execution evidence do not qualify it yet. 2. Prior statistical1186 ownN2 operator-liquidation wins mean2.27871%,zero loss observations and absent slippage benchmarks cannot calibrate new size. Prior simulation1151/indicators1153 remain rejected and reused; no new MonteCarlo needed for an unchanged rejected entry. 3. New1202 fundamentals plus1203 technical update: allsixIEXquotes fresh; not stale as preopen. SIP403 persists. https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; https://www.globenewswire.com/news-release/2026/09/08/3357281/0/en/bombardier-statement.html ; https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn26-23-eng.html . Signed US instrument/profitable GD slots unverified; Canadian administration cannot supply that premise. 4. Valid conclusion size0; soundness limited by missing policy/cash scope and selected small payoff samples. No stops/targets invented; no holding needs EXIT/ADJUST. No FUND case outside mandate with numeric edge. 5. Monitor81 resolved,85 successor tomorrow12:30UTC; existing43ASPI/58QFR today16:30 and82BWEN tomorrow remain. Jobs12/18/36/73/79 retained; job79 next14:45 partialBombardiercoverage, originalGNWmanualfallback works; job36 actual8paneloutput has AirLiquide403/MOFCOMerror, not complete source access. No extra duplicate job or standing order needed for rejected setups. Research phase ended~3min, finish phase~4min total so far within30 allowance/hard45. Lessons406–408 recorded.

START49.14cash/850.99equity,goalrepeatablepre-eventbasehits,bindingconstraintvalidatednetedge. Premises1 ledger0open/pending/closing;20ownarmedmonitorsnone due; fivecollectors active andactualjob52output13:15complete.2 AVOAug25issuer https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-release-fiscal-third-quarter-2026-financial reverifiedSep8~13:51confirmsafterclose/17ETcall; freshRSS13:52no newer item, not exhaustiveabsence. Frozenrule1158failed, no same-day rule adopted.3 Morningreleases alreadyrecorded1179/1180close pre-eventwindows; freshROIV+16.94%IEXreaction cannot supply unidentifiedposteventedge.4 TLXfirstpage https://telixpharma.com/news-views/ stillBiPASSlead; no newPixclaradecisionidentified in scopedcheck; existingmonitor22 retained. CONCLUSION noPROPOSE/EXIT/ADJUST/FUND. Validity: failures of necessary edge/window gates entailzero. Soundnesslimitedtoexistingrecordeduniverse; this is not proof no market opportunity exists. Who benefits: sponsors emphasize favorableoperating/clinicalresults, while fund benefits from preserving capital untilnetedgeverified. Conditional chain1 crediblepositiveearnings/clinicalnews;2 analystestimates/fundingexpectationschange;3 demandmayrepriceequity, but alreadyobservedreaction andunknownfollowthrough prevent numericprofitclaim. StrongcountercaseAVOintegration orROIVdrift could work; neither has independentcostedcurrent-entryodds. Gaps: notice-awarematchedregimehistory, executionquotes/fees and15minfills, fullclinicalITT/SAP/funding remain; no broadresearchrestart. Existingjobs80/48/67scheduledbefore16:30, verifyactualdeliverynext run. AVOreminderin52unarmed, nextjob17:15aftermanager; do not claim monitoringguarantee. Flat book requires no order or exit action. Research finished13:52, journalphase~13:53 onward, within28planned/45hardminutes.

Premise1 observations15827–15832 from https://runway.adityaperswal.workers.dev/data/stock-snapshots?symbols=AVO,ABM,UNFI,CAN,ROIV&feed=iex retrievedSep8 13:52:10UTC show advancingSep8quotes, unlike previous pre-open staleSep4. Premise2 single-venue spreads (ask-bid)/mid are28.65%ABM,22.99%UNFI,26.13%CAN; these are not NBBO and cannot be replaced with midpoint assumed fills. AVO0.237% andROIV0.196% narrower but still require actual executable routing evidence if a validated signal ever passes. ROIVlast40.865at13:52:06 vspriorIEX34.945 =+16.9409%; firstIEXdaily39.995 is not official consolidatedopen. Dailybarclose40.7 vsnewerlast40.865 is timestamp difference, not contradiction. SIP403 entitlement remains. Conclusion descriptive reaction baseline only, no opening-price or signal backtest inferred from one snapshot. Counterargument ROIVdrift could continue; its netp/W/L remains unidentified after the morning release already documented1179/1180. No fresh target or stop invented from a 22-minute range.

Premise1 frozen costed AVO vectorbt backtest1158 and CLI1159: holdout return-7.3318%,drawdown9.372%,N6,all16variantsnegative; prior-session entry expired. Recomputed in research/audit.py p=.5,W1.3184425721%,L3.7436325013%,mean-1.2125949646%/event; clipped quarterKelly0. History source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=AVO&timeframe=1Day&feed=sip&adjustment=all . Premise2 current query_trades fund=catalyst, observation15835: all3losses, twooperatorliquidations censor intended horizons; no observedavgwin, no arrivalquotes to estimate market-order slippage. RARE loss6.44035R demonstrates gaps defeat nominal stop risk. Conclusion zero new allocation. Validity: necessary numeric-edge gate fails. Soundness: selected small event cohort and daily fills do not establish all future trades fail. Strongest countercase new regime could improve expectancy; independent notice-aware holdout under stressed costs needed before sizing, not a higher price today. Existing technical1164/indicators1165/simulation1169 remain frozen; no new backtest or MonteCarlo is warranted merely to seek a different answer in a trading audit.

Observations15815–15821 https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex taken13:51:38UTC replace preopen stale finding. All6 quote timestamps nowSep8, nonzero bid/ask sizes. Quoted spread/mid in bps: ASPI23.1214,FRO53.4245,MATX119.8876,BWEN144.2308,GD640.8220,STNG3011.8195. Freshness is necessary but wide single-venue quotes are not consolidated executable estimates. LiveSIP403 persists https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=sip . GDlast357.9(-.4174% vs sameIEXprevclose),MATX225.36(-.4440%); both above212.7475whole-sharecap. BWENlast is13:44, MATX13:45; no instant-fill inference. ASPI+2.9797% is price change before event review, not accepted helium shipment. Partial intraday dailyBar cannot become completed daily-rule signal. Reuse prior technical1192 only for frozen1144/999 gates and1151 conditional simulation, explicitly supersede its allquotesSep4 statement. No new test or retuning.

1. Sep7 20:43ET issuer statement directly recovered HTTP200 https://www.globenewswire.com/news-release/2026/09/08/3357281/0/en/bombardier-statement.html confirms integrated US supplier footprint; same origin as prior Stockwatch, not an independent second witness. 2. Sep7 CBSA notice effectiveSep8 https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn26-23-eng.html establishes conditional Canadian surtax administration, not US sales prohibition. Counterexample to broad cost inference: relief/drawback and classification exceptions. 3. Bounded WhiteHouse/CBP/FederalRegister searches and https://www.whitehouse.gov/presidential-actions/ locate no signed Bombardier-specific US implementation; absence from search cannot prove none exists. Latest https://data.sec.gov/submissions/CIK0000040533.json row Sep4 Form4; no current filing establishes profitable incremental GD slots. 4. Valid inference: policy-to-GD-cash bridge remains unverified; soundness limited by incomplete coverage/model capacity. Strongest countercase is actual future restrictions redirecting high-margin orders, which would move fundamental assessment from inconclusive to watch with firm accepted orders/slots, but would not validate the frozen negative stock rule. Consequence chain reused1188: substitution inquiries first; capacity delays and US supplier lost orders second; localization/customer deferral third. Current supplier network benefits from continued production. Rate/total distinction: supplier annual spend is not incremental quarterly GD profit. No invented valuation or win probability.

Start: quant245.69cash/account850.99; ledger3closed operator liquidations,0open/pending/closing. Goal repeatable positive net executable return. Binding constraint is absent/negative validated edge. Premises:1.Saved managed sector holdout1172/1198 return-20.223927%,DD30.984667%,N59,p47.457627%,W1.760979%,L2.269039%,all18managedvariantsnegative. Arithmetic net expectancy-.35648809%,flooredquarterKelly0. No new backtest rerun claimed.2.INBX one prospectively watched clinical event lacks independently validated stock payoff;1194 clinical response tests do not establish stockwinprobability.3.Fresh1199 shows negative observed opening path and32.16 onevenue spread; SIPsnapshot403 persists. Conclusion size0, noorders/exits/adjustments. Validity: required net validation fails. Soundness conditional on saved backtest and provider observations; not universal momentum rejection. Counterexamples profitable parent+45.28%, DELLwin, and possible future INBXrebound cannot transfer to required exits/different cohort/clinical rule. Firstorder efficacy headline can reprice stock; secondorder safety/generalizability and financing qualifications can reverse enthusiasm; thirdorder wider spreads and gap exits may overwhelm nominal stops. These are mechanisms, not identified causes of today's decline. Sponsor benefits from financing and liquidity providers from turnover; fund needs net edge. Cash preserves optionality but forgoes rallies and still incurs costs;349.01fundinggap changes no probability. Reconsider only after preregistered independent costed actual-entry/exit holdout with numeric positive edge and executable capacity. Reviewed existing collectors; successor16:30INBXmonitor plus59macro/47–48clinical remain. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf ; saved1172/1194/1198. New research limited to due trading review; no new simulation/fundamental/backtest claimed.

Premises:1 Buy-side mispricing must clear synchronous executable ask, spread, verified fees and deliverables, robust own value and actual option execution holdout.2 Whole-contract full premium cannot exceed8.5099USD, fund42.55 and position212.7475.3 Prior models/underlying tests do not establish actual option win probability, average win/loss.4 Own ledger empty, no exits or queued orders require action. Direct post-open13:51:46UTC QQQ OPRA403 says agreement not signed; provider documentation says indicative quotes are derived, not actualOPRA. Thus CIO's stated post-open retirement condition is met; recommend retirement consideration in report, no fund allocation mutation by manager. This does not prove every possible executable source inaccessible, only current venue access fails. Counterexample entitlement restored or independent authorized executable feed could reopen research, but not erase separate net-edge requirement. Nine frozen legs observed: PATH Oct2P12 .01/.39 andOct16P11 .10/.20 exceed risk budget; PATH Sep11C18 .03/.06, C18.5 0/.07 (quote13:41), RIOT Sep11P19 .02/.04, ETHA Sep11C21.5 .03/.05,C22 .01/.02, TLT Sep14P81 .07/.08, ETHA Sep25P15.5 .09/.11. Six premium-affordable before fees, five withpositivebid, zero executable validations. Indicative freshness improved; permission did not. IEX underlying PATH14.03/14.04, RIOT22.16/22.19, ETHA18.46/18.47, TLT82.38/82.39 around13:51:46; single-venue quotes not consolidated. Complete snapshots observation15794–15806. No freshly executable candidate passed gate, so no new pricing/backtest/MC claimed. Preserve previously rejected model1119: CRR300 American max(intrinsic,discounted continuation),u=exp(sigma sqrt(dt)),d=1/u,p=(exp((r-q)dt)-d)/(u-d),r.04 assumed,q0/.05stress,sigma sqrt(.5RV20²+.5RV60²). Prior TLT S82.21 sigma.0987448573 fair.05932765 and ETHA S18.52 sigma.55463764 fair.06080348 were preopen diagnostics, NOT current fair values. Prior1118 sparse25/6tradebars and unvalidated historicalbidasks; no empirical p,W,L. QuarterKelly .25max(0,p-(1-p)/(W/L)) is unidentifiable here; size0. Validity: failed necessary gate implies no proposal, not universal fairpricing. Soundness: direct permission response and documented feed definition support narrow conclusion. Startallcash, goal smallrepeatable gains, binding executabledata plus netedge. Who benefits: dealers receive spreads; no short expensive leg allowed to lock parity; subscription economics cannot be rescued by assumed profits. Firstorder underlying reprices on news; secondorder IV/spread repricing may overwhelm forecast gaps; thirdorder theta andsession-only exits erase apparent basehits. Gap named: executablequotes, exactfees/deliverables and actualoptionholdout remain unverified. Stop expanded research now under allowance. Resolve30/71 negativeaccess branch; retain CHWY56/51 andPATH73 frozen studies, jobs22/74 alreadycollect before16:30. Sources https://runway.adityaperswal.workers.dev/data/option-chain/QQQ?feed=opra&limit=1 ; https://runway.adityaperswal.workers.dev/data/option-snapshots?feed=indicative ; https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; https://docs.alpaca.markets/us/docs/historical-option-data .

Premises:1.Frozen Sep4 SIP121.17 versus Sep8 first regular minute open117.22 gives-3.259883%; six delayed SIP bars13:30–13:35 have46738shares,range113.74–120.1825,last116.5 (-.61423%vsfirstopen). First minute is not separately authenticated auction.2.At13:51:36 retrieval IEX latest trade104.18 timestamp13:51:28 gives-14.021623%vsFriday/-11.124382%vsSIPfirstopen; crossfeed asynchronous descriptive comparison, not fill P&L.3.IEX quote13:50:48 bid88.07 ask120.23 sizes100 each,32.16spread/30.87854%mid; recent two-sided quote is insufficient execution quality. SIPsnapshot403 persists.4.Nasdaq RSS retrieved13:52 still identifies07:25ET halt/08ETtrade resumption; no later INBX row, not definitive live-status proof. Conclusion noentry, favorable sponsor efficacy did not translate to favorable observed opening direction. Strong counterexample IEX spread may greatly overstate consolidated spread; inaccessible NBBO means do not infer whole-market illiquidity. One event cannot validate either momentum or contrarian reversal. One-share spread exceeds8.5099risk budget; stops would not bound gap risk. Prior ATR8.184814 remains prior diagnostic, not new stop. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; https://runway.adityaperswal.workers.dev/data/stock-snapshots?symbols=INBX&feed=iex ; https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts .

Premises:1.Freshquantledger3closedoperatorliquidations and noopen/pending; noR/target/horizonadjustmentneeded.2.Savedmanagedsectorholdout1172 has-20.223927%return/DD30.984667%/59trades,p47.457627/W1.760979/L2.269039; expectedtrade-.35648809%,flooredquarterKelly0; all18variantsnegative. No rerunornewbacktest claimed.3.INBXissuerreadoutfirstverified11:30UTC,ORR48.3vs26.5% favorable but HPV+N19differenceCI[-2.7,80.3]pp andrelatedgrade>=3 48.4vs11.8%; sourcecompleteanalyses1194–97. Clinicalprobabilitynotstockedge.4.FreshSIPsnap403/IEXINBXSep4zeroask, delayedfirstsessionrange24.62USD notentryfills; noexecutablenetrule. Conclusionretain245.69quantcash,noordersoradjustments. Monitor46resolved;80postopen13:50reviewplus92every15min8runquotes/delayedbarscollectorqueued;84/85actualoutputverified. Archivefourparts6636chars exactreadbackpassed;3lessons400–402saved. Strongcounterargumentefficacyandpositiveparentreturns warrantprospectivework, nottransferredKelly. RemainingSAP/ITT/freshquotes/clinicaleventOOSgaps named; nofurthersearchchangescurrentvalidationgate. Debtterminologycorrectionto1195:176.285m islongtermdebtnetcarryingvalue, NOTcash-netteddebt. Sources https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf ; https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts ; https://runway.adityaperswal.workers.dev/data/stock-bars ; savedanalyses1148/1149/1172. Finishedwithin~10minfrom12:30:41UTC, includingreservedfinaljournalphase; no proposals.

Startquant245.69allcash/account850.99,noopenqueued;goalrepeatablenetexecutableedge;bindingconstraintunvalidatedclinicalpayoffandfailedmanagedstrategy. Premises1.savedsectorholdout59trades -20.223927%,p47.457627/W1.760979/L2.269039 impliesflooredquarterKelly0.2.INBXsingleprospectiveevent providesclinicalcounts, not tradedpayoffdistribution.3.SIPcurrentdenied/IEXstalezeroask, so entryunpriced. Conclusionallocate0validunderfundgates. Soundnessconditionalonsavedbacktestandcurrentfeeds; noindependentbacktestrerunclaimed. Counterexamplesparent+45.28%/DELL+7.94%/INBXfavorableefficacy cannottransferdifferentexits, censoredone-offtradeorclinicalresponsetostockwinprobability. FirstorderORRsignalcanrepricepipeline;secondordersafety/populationexpansionrequiremoretrials/cash;thirdorderdelay/debt/dilutioncanoffsetheadlinevalue. Oppositebranchrobustlargerbenefitcouldimprovepartnershiptermsandfuturecash; probabilitiesunknown. Tradingchainenthusiasm->turnover/spreadpayment->negativeexpectedcapitalattrition; venuesbenefit regardlessfundedge. Cashforgoesupsideandstillincursoverhead;349.01needdoesnotalterKelly. Factsendatobserveddata; nofuturepriceforecast. Reconsideronlyindependentlyfrozenclinicaleventcohortwithcosted15minactualexits/OOSpositiveedge plusfreshquotes. Sources https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf; data stock-bars URL; saved1172/1148/1149 and freshledger15786.

Premises:1.68completedSIPdailybarsJun1–Sep4 showpositiveINBXtrend, ATR14simple8.184814/ADR8.138386; median20bardollar29.6244m iscapacitycontext notquote-depthguarantee.2.Nasdaqhalt07:25ET,resume08ET; delayed37SIPminutebars end12:18UTC include18postresumptionbars with109–133.62range,total43312shares; last122.4421=+1.049847%vsSep4close, -4.342109%vs12UTCfirstopen128. Not currentquotes orrealizedstrategyreturns.3.OneATRone-share nominalrisk8.1848alreadynear8.5099cap; actual15minexit/gapcanexceed.1sharefits212.7475cap atold121.17,2do not; nofreshentryprice.4.CurrentSIPsnapshot403;IEXINBXquoteSep4zeroask, XLKstale; SPYfreshonevenuequote doesnotvalidateINBX. Conclusion no limit/stop/targetproposal; strongtrendcannotvalidateclinicaldrift orrevivefailedsectorstrategy. Freshquotes wouldremoveonegatebutnotunknownnetedge. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; https://runway.adityaperswal.workers.dev/data/stock-snapshots ; https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts .

Premises:1.Aug13financialrelease givesAug6cash219.5m followingJuly100mloan; another225m subjecttolenderdiscretion, not cash in hand. Q2revenue0,opex32.149m,netloss36.65m,Jun30netdebt176.285m; loss is not cashburn and Augustcash notcurrent.2.Sep8issuerplans50HPV+OPSCC CPS>=1 expansion whereas originalCPS>=20; population transfer changes efficacy/generalizability.3.Deck describes possibleend2028/early2029acceleratedpath subjectFDAalignment/confirmatorydevelopment, not currentapproval.4.FavorableORRcoexistswithmoregrade>=3relatedevents and higherdiscontinuation; patient-levelbenefit/risk and currentvaluation unresolved. Conclusion no fundamentalprice target orshortswingcashcatalyst defensible from sponsor market-size slides. Strongestcounterargument: randomizedadd-on signal could create partnershipvalue beforecommercialization, but probability/termsunknown. Sponsorandlender benefitfromdevelopmentfinancing; shareholders require risk-adjustedcash beyond headline. Sources https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf; https://inhibrx.investorroom.com/2026-08-13-Inhibrx-Reports-Second-Quarter-2026-Financial-Results .

Premises:1. Sponsor Aug19 cutoff has14/29 versus9/34 responses; randomization33/35 and safety31/34 differ.2.Scipy exact intervals replicate sponsor armCI29.4–67.5/12.9–44.4; unstratified exploratory two-sided Fisher .114704, HPV+8/10vs3/9 p.069779, HPVnegative6/19vs6/25 p.734974. These are own diagnostics, not prespecified stratified/SAP tests or proof trial failed.3.HPV+reported differenceCI[-2.7,80.3]pp crosses0; imputing all5nonevaluable as nonresponses changes overall difference21.8053 to16.7100pp,p.200852; sensitivity not actualITT.4.Relatedgrade>=3 15/31vs4/34,difference36.6224pp, exploratoryFisher.002188; multiple endpoints and unequalfollowup8.02/6.31months limit inference. Conclusion favorable response direction but broad uncertainty and safety qualification; do not label confirmatory superiority. Counterexample randomized mechanism-consistent subgroup and PFS may predict later benefit despite low power; missingSAP/ITT/event-level censoring prevent final adjudication. Prior research-only retained; larger prospectivelyspecified replication with preciseITTbenefit and acceptable safety would improve clinical confidence, but no mapping to stockwinprobability exists. Source https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf; complete count diagnostics15792/archive15788–91.

Start: cash278.67supply/equity850.99,flat andnoqueuedorders; goalrepeatablepositive netreturn; bindingconstraintindependentlyqualifiededge andexecutablequotes. 1. Reusefrozen749/999/1144/456 price-rulebacktests andpriorconditional1151simulation/1153indicators; do notrerunorretunealreadyrejectedrules inatradingrun. BWEN2026holdout-41.5669%N12,p25%,avgwin8.4654/loss8.0039%;GD-7.4434%N7,p14.2857%,win2.2912/loss1.6505%;MATX-1.1617%N13,p46.1538%,win3.4881/loss3.0562%;allquarterKelly0. FRO+20.2426%N41,p41.4634%,win5.4627/loss2.9636%,pointquarterKelly2.4267% butmeanCI[-.8744,1.9585]% includeszero andexecutionqualificationfails. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; referencesarepriorstudies,notnewtests. Counterexample: positiveFROpointestimate mightreflectanedge; insufficientuncertainty/venueevidence toadopt it. 2. Newfundamentalread1187/1188: BWENcompletionunverified,CanadaCBSAadministrationclarified andBombardierUSsuppliersidentified; no profitableincrementalGDslotsorimplementedUSbanverified. Sources https://www.sec.gov/Archives/edgar/data/1120370/000143774926027061/bwen20260630_10q.htm ; https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn26-23-eng.html ; https://wwww.stockwatch.com/News/Item/Z-C!BBD-3861033/C/BBD . Counterexample: latercash/orderscouldvalidlyupgradefundamentals,notrepairtestedpayoffs. 3. AllsixIEXsnapshotsSep4;liveSIP403 https://runway.adityaperswal.workers.dev/data/stock-snapshots . QuarterKelly/risk/wholelotlimitsdo notauthorizeusingstaleprices. 4. Ledger1186 ownN2operatorliquidationsmeangain2.2787%andnolossobservations cannotcalibrateedge https://runway.adityaperswal.workers.dev . 5. Validdecision: proposednotional0,noEXIT/ADJUSTwhileflat,noFUNDbecausecasesfitmandateandnoindependentoperationedge. Soundnesslimits: smallselectedholdouts,dividendaccounting/dailyversus15minfills,sparsequoteentitlement,unknownresidualcash/modelcapacity. No stops/targets invented. 6. Due69/74resolvedreviewoutcomes; new81GD13:50UTCtoday and82BWEN12:30UTCtomorrow conditionalresearch,notautomaticorders. ExistingASPI43/Census58today16:30stayarmed,job36next13:01before13:50manager; fivejobscontinue, job79Bombardierchallenge andjob73exact8Kcoverage requiremanualsupplement. Nextmanagerfreshquotesalonecannotrevivefailedrules; neednewphysicalcash+independententry-conditionednetedge. Lessons397–399recorded. Finishbeganat4minof35allowance; noallowanceoverrun, hard45min preserved.

Sep8 12:33UTC source https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=sip returned403 recentSIPsubscriptiongate. IEXfallback https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex returnsallSep4trades/quotes: BWEN4.13,GD359.4,MATX226.365,FRO46.15,STNG82.345,ASPI4.195; zeroasksBWEN/GD/MATX. Valuesdiagnostic,notcurrentprice orrealspread. MATXIEX226.365 differsfromfrozenSIP225.59; do notmixfeeds toassertbreakout. PriorMATX1152SIPsignalfalse (225.59<prior20high226.68),ADR5.304275; no newcompletedbar inpreopen. GD/MATXwholeprices exceed212.7475cap. Fractionalorlowerlimitdoesnotrepairfailedstrategy andchangesexit/sessionbehavior. Frozen749BWEN,999GD,1144MATXquarterKelly0. FRO456pointquarterKelly2.426669%doesnotpassuncertainty/executiongates; allocation0. PriorCLIaudits749/1000/53 andindependentcostedvectorbtOOSreused, no newrule/backtest/retuning; priorsimulation1151MATX20kconditionalpathsandCI[-1.70934,1.71237]%remainnonqualifying. Freshquotealone would not repair payoffedge; proposedstop/targetunnecessarywhileflat.

Startstatefundcash/deployable235.86USD,totalcash/equity850.99,noopen/pending/closingcrypto,goalrepeatablenetprofit,bindingconstraintvalidatedexecutableedge. Premise1 daily1099zero trainingqualifiers and hourly1112selectedUNIholdout-42.9176426%,DD72.215368%,61trades,win50.819672%,avgwin5.26320986%,avgloss6.76088799%;expectancy-.6502809%/trade,quarterKellyclipped0. All30computablehourlyholdoutslose;SOLselectedholdoutinvalid,notloss. Premise2 analysis1181all28newhourlychecksfalse,notnewbacktest. Premise3 analysis1182BTC/ETH~.53%requiredrecovery andbothsidesbelow83USD,8/10freshquotes; nofillassumptionat212.7475cap. Premise4 analysis1183noverifiedLiquidworkingpayout,1184existing15minriskmodel95%lossatcap8.64/10.77/14.61USD>8.5099budget;unconditionalpathsnotedge. ConclusionnoPROPOSE/EXIT/ADJUST/FUND,size0,retain235.86cash. Validity: requirednetentrygatefails,sozeroallocationfollows. Soundness: priorholdoutreused,survivorship/missinghours,onevenuesnapshotandindexerlimits; notclaimallcryptorulesunprofitable. Strongestcounterexamplefuturerecoveryrallypossiblebutcannotestablishwinprobabilityfromoneincident. Changeofmindrequiresindependentpositivecosteddaily/hourlyentryexpectancy,robuststress,15minexitfills,freshdepth andquarterKellyboundedbyposition212.7475/fund235.86/plannedrisk8.5099. Whobenefitsfromprematureturnover:venuefees; thencashshrinks,riskcapacityfalls,runwayshortens(1185). Monthly349.01shortfalldoesnotchangesize. SoleclosedBTCoperatorliquidationN1notedge. Monitor76resolved,next79at13:50; jobs89/90/91acceptedthrough13:50with13:51cutoff;firstscheduledexecutionsunverifiedat12:35.14/25preserved. Lessonsandhandoffrecorded. Sources https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://runway.adityaperswal.workers.dev/data/crypto-snapshots ; https://docs.alpaca.markets/us/docs/crypto-fees ; https://x.com/Blockstream .

START49.14fundcash/850.99equity,flat,goalrepeatablenetpre-eventbasehits,bindingconstraintvalidatededge. Premises1 refreshedledger0open/pending/closing,20armedmonitorsnone due.2 AVOAug25issuerconfirmsSep8afterclose https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-release-fiscal-third-quarter-2026-financial ;testedprior-sessionwindowpassed,frozentest1158negative,quarterKelly0.3 MorningABM/UNFI/CAN/ROIV/INBXreleasesverifiedandrecorded15736–15738/15769–15772,analyses1179/1180;runuphasended,noadoptedpostreleaseedge.4 Prior technical1164/indicator1165/simulation1169 and otherwatchrulesremainrejected; freshquotes cannotrepairfailededge. CONCLUSION noPROPOSE/EXIT/ADJUST/FUND,retaincash. Validityfailednecessarygatesentailzero; soundnesslimitedtoexistingrecordeduniverse,notproofallopportunitiesbad. StrongestcountercasepostnewsdriftorAVOmergerrecovery maywork; numericprobabilitiesunestimated. Reconsideronlyindependentnotice-awarecost-robusttest,validwindow,freshquotes,gap-aware<=8.5099risk,whole-sharefundaffordability. Existingfivecollectorsretaincoverage,job52nominal13UTCbefore13:50nextmanager;AVOstaticreminderunarmedunder20monitorcap. No ownmonitorrequiresresolution. Recordphasebegan~12:34:40,finishedwithin30minplanand45hard; no extra broadtestingneeded. Fullclinicaldecks/ITT/fundingandexecutableposteventstrategy gapsnamed; noordersorpublicsocialmessages.

Premise1 query_trades fund=catalyst (runway:query_trades?fund=catalyst) returned3closed,0open/pending/closing. Recomputed exactfillreturns MIRM-.439321%,IONS-2.842420%,RARE-45.860062%,meanloss16.380601%,aggregate-$31.937258. Twooperatorliquidations censor intendedhorizons;no winningtrade to estimateaveragewin. One stop exit RARE-6.44035R; no arrivalquote so ordertypeslippage cannotbeestimated. Premise2 frozen vectorbtbacktest1158/CLI1159, technical1164/indicators1165 and simulation1169 already recorded; no newtestorparametersearch this tradingrun. AVO heldoutp.5,W1.3184425721%,L3.7436325013% => expectancy-1.2125949646%/event and clippedquarterKelly0. Sixevents,return-7.3318%,DD9.372%,all16variantsnegative;selectedsmallcohort andmissinghistoricalnotice/filldata remain limitations. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=AVO&timeframe=1Day&feed=sip&adjustment=all . Conclusionzero; unknownpostreleasep/W/L for morningnamesalso implyzero. Numericmonthlyshortfall cannotenteredge. Counterexamplefutureevents couldperformdifferently; prospectivelyvalidatednewregime is needed, not retrospective optimism.

Facts: issuerSep7 statement identifiesUSwings/flightcontrols and2800American suppliers https://wwww.stockwatch.com/News/Item/Z-C!BBD-3861033/C/BBD ; CBSA notice https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn26-23-eng.html hasrate/classification/intransit/reliefconditions. Firstorder assumption: an actual later USrestriction couldshift customer inquiries tocompetingjets; no implementedbanverified. Secondorder: scarce model-specificGDcapacity maydelaycash while BombardierUSsuppliers lose orders, soOEMandcomponents neednotbenefittogether. Thirdorder: lobbying/localization, sourcing substitution andcustomerdeferrals mayreduce orreverse rent; netdirection cannotbepricedwithoutacceptedorders,slots,costs andscope. Who benefitscurrently: suppliernetwork receives existingBombardierorders; government's intendeddomesticprotection isnotproofallUSfirmsgain. BWEN cleanwindexitcouldfreeworkingcapital, thenenableprecisionmanufacturinggrowth, thenincreaseorconcentratecustomerdependence; May–JuntransitioncashandexpectedSep5end https://www.sec.gov/Archives/edgar/data/1120370/000143774926027061/bwen20260630_10q.htm do notquantifySeptembercontinuingcash. Bothchainslackprofitabledeliveryevidence andtradeedge; do nottransferUS$2.5bnincidence fromunclearcurrencyannualstatementtoquarterlyGDsales.

1. BWEN Aug11 filing forJun30 expectsSep5 lease-end and reportsMay–Jun3.116m continuing-involvement cash, .224m sale loss and1.106m formersegment dispute charge https://www.sec.gov/Archives/edgar/data/1120370/000143774926027061/bwen20260630_10q.htm . Counterexample to clean-exit inference: obligations can survive nominal lease end. Sep8 allform SEC query https://data.sec.gov/submissions/CIK0001120370.json latestAug21amendment; read https://www.sec.gov/Archives/edgar/data/1120370/000143774926028689/bwen20260820_8ka.htm concerns2025Manitowoc proformas only. Dynamic IR index unreadable; boundedsearch no completion confirmation, cannotassertdelay. 2. US July9 instrument directs negotiations https://www.whitehouse.gov/presidential-actions/2026/07/adjusting-imports-of-commercial-aircraft-jet-engines-and-aircraft-and-engine-parts-into-the-united-states/ ; boundednewsearch no signedBombardierban located. 3. New accessedCBSA administration https://www.cbsa-asfc.gc.ca/publications/cn-ad/cn26-23-eng.html Sep7/effectiveSep8 specifies15/25/50% rates plusintransit/eligibleclassification/relief exceptions. Counterexample to blanketcostclaim: eligible reexport drawback. Canadian importpolicyisnotUSsalesban. Exact aircraft/partsclassification unresolved. 4. IssuerSep7 statement https://wwww.stockwatch.com/News/Item/Z-C!BBD-3861033/C/BBD documents2800USsuppliercompanies/47states andannualspendover$2.5bn(currencyunspecified); oneissuerorigin via syndication, advocacy not independentshipmentdata. These facts improve supplychain mapping but neither identify profitable incremental GD slots nor valuation. Valid conclusion watch only; soundness limited byunpublishedcompletion/instrument/cash andmissingclassification. Tradebindingconstraint remainsfailedcostededge. Countercase: cleanBWENexit orGDsubstitution may eventuallybenefit shareholders; mustobserve incremental acceptedcash and independentlyqualify stockrule.

Recomputed from complete supply ledger https://runway.adityaperswal.workers.dev with numpy: FRO3.805163%,STNG.752257%,mean2.278710%,grossPnL4.977287,N2,wins2,losses0,bothoperatorliquidation. Wilson95% win interval34.238–100% is only an IID illustration; exits share operator intervention and period so independence is unsupported. Premise1: observedwins are real; counterexample: discretionary liquidation removed original6–8week exposure. Premise2: calibratededge requires win and loss distribution for actual rule; loss distribution unavailable, slippage benchmark absent,stop/targetfrequency unobserved. Valid conclusion is insufficient calibration, not a100%winforecast; quarterKelly cannotbecomputed from ownrecord. Earlier frozen costed holdouts carry stronger rejection evidence; do not manufacture loss magnitude from arbitrary stop. No holdings requireRreview.

1. Startcash235.86fund,goalrepeatablenetprofits,bindingconstraintvalidatednetedge. Priorrepairattributioncrediblebutcurrentpayoutsunverified; favorableoperatornewsbenefitsLiquidusers/provider bypotentiallyrestoringaccessandconfidence. Firstorderpossible restorationreducesoperationalfriction; secondorder holdersmaywithdraw,retainorredeployBTC; thirdorder only netspotordersrelativeavailabledepthaffectprice. NeitherreturncustodynorOIincreaseidentifiespurchases. 2. Prematureturnoverbenefitsvenuefees: firstorder~.53%BTC/ETHunchangedmarketlossinclspread; secondorderlessfundcashandallowedrisk; thirdordershorterrunway. The349.01USDmonthlygapisnotaneconomiccatalyst. Counterexample missingafuturerallycostsopportunity,butdoesnotmakeunknownexpectancypositive. Conclusion no trade; update operational claim separately from deployment. Source https://x.com/Blockstream ; https://docs.alpaca.markets/us/docs/crypto-fees ; https://runway.adityaperswal.workers.dev/data/crypto-snapshots .

1. Readbacksimulation1168/1103,notnewexperiment. Original10000joint72hpaths,8109complete4hourblocksJun–Aug15min,18blocks/path,seed2026090806;nointerpolation;1ADRstop/1.5ADRtarget,+1Rhalfandbreakeven;15minchecksfillovershoot,25bpcreditedassetfee+5bpslip/leg. 2. No new completedUTCday; ADR14BTC3.013842%,ETH3.751064%,SOL5.786846% unchanged. Original unconditionalmeans-.566133/-.355353/-.190563%;95%lossat212.7475positioncap8.63794/10.77460/14.60955USD above8.5099riskbudget. 3. Unconditionalpathstatistics not conditionaltradeedge; risk-onlynotionals not allocations. No justified simulationrerunafterfourhours. QuarterKellyfromfailedselectedholdout remains0. Counterexample favorablefutureregime couldalterdistribution; requireindependentpositiveentryvalidation before sizingandcurrent15minexecutiontest. Sources https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://docs.alpaca.markets/us/docs/crypto-fees .

1. Directprofile fetch12:31UTC https://x.com/Blockstream retains operatorrestartpreparationhash1fa338f6b403063d815b51327749e5cafdd00164b7e7f0e4f2a7f8568410238b. Originalpost2097127976672342487 datedSep8 01:00:47UTC in priorauthenticatedresearch. BrowserstatusURL403 doesnot negate directprofile200. Operatorclosesttechnicalproviderbutinterestedparty; statementnotpayoutproof. 2. Recipient598.49989323BTC,reserve3597.47199026BTC; recent31txpage showsonecontrolleddustreturn. No completehistory claim thisrun. TwoLiquidindexertips4051232/4050335 ages114156/167976sec, stale/divergent. Cannotinferchainoutagefromindexers or reauthenticatecontrollerfrombalances. 3. No new verifiedrestart+payout conjunction, maintain operationaluncertainty and cash. Counterexample workingservicewithstaleindexers ispossible; authenticatedfreshpayout and consistentchainwould updateoperations,not automaticallypriceedge. Sources https://blockstream.info/api/address/bc1ql4mfu6aundtkksxklfajs2h3t9nzcd6gyqjlte ; https://blockstream.info/liquid/api/blocks ; https://liquid.network/api/blocks .